RBC Capital Maintains Outperform Rating on PayPal (PYPL)

UBS Raises MercadoLibre (MELI) Price Target, Keeps Buy Rating

Barclays Keeps Overweight Rating on Mastercard (MA) Despite Stablecoin Concerns

Citi Stays Positive on Visa (V), Keeps Buy Rating

Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating

Craig-Hallum Reiterates a Buy Rating on Clover Health Investments (CLOV), Sets a $6 PT